ConCallIQ
Go Pro
PI Diversified 10 Feb 2026

PI Industries Ltd — Q3 FY26

PI Industries reported Q3 FY26 revenue of ₹1,376 crore, reflecting continued global agrochemical headwinds.

bearish medium
Compare with...
Revenue ₹79 Cr
EBITDA
PAT ₹12 Cr
EBITDA Margin 34%
Duration 50 min
Read Time 1 min read

✓ Verified against BSE filing

Risk Intelligence

Material risks this quarter

Concise cards keep the risk register scannable while preserving evidence-level context in the underlying quarter data.

Risks

R

Prolonged global demand weakness

Extended downcycle in global crop protection market due to low commodity prices and geopolitical uncertainties could delay recovery.

high · management_commentary
R

Slow conversion of pharma and biologicals investments

Pharma and biologicals businesses are incurring quarterly losses of ₹75-80 crore, and breakeven may take longer than expected.

medium · analyst_question
R

Working capital pressure

Trade working capital days increased sharply to 139 days, reflecting market conditions and partner support needs.

medium · data_observation
R

Regulatory hurdles in domestic biologicals

Regulatory issues in Indian biologicals market have impacted portfolio, though management expects resolution by Q4.

medium · management_commentary